The Guardant360 assay kits

Location

United Kingdom:

Description

The Guardant360 assay kits are required to deliver the Trust's partnership agreement with Guardant Health. This is the only kit that can be used to deliver this and is included in the contract requirements with Guardant.

Total Quantity or Scope

The G360 assay designed by Guardant Health is run using Guardant's proprietary sequencing reagents and bioinformatics pipeline and as such an alternative sequencing assay cannot be used. This is direct award to Guardant Health due to designed kits which are needed to run the Guardant assay.

Award Detail

Award Criteria

CPV Codes

• 33910000 - Pathology dissection instruments and supplies

Legal Justification

There is only one supplier i.e. Guardant, we have to use their kit to run the Guardant assay, there is no alternative. We have formed a partnership with Guardant to provide this service. Guardant360 CDx utilizes circulating tumour DNA (ctDNA) from plasma of peripheral whole blood collected in Streck Cell-Free DNA Blood Collection Tubes (BCTs). Guardant360® CDx is a qualitative custom designed next generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 55 genes, copy number amplifications (CNAs) in two (2) genes, and fusions in four (4) genes.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **